Literature DB >> 8682588

p53 accumulation and mutation are prognostic indicators of poor survival in human gastric carcinoma.

B H Lim1, R Soong, F Grieu, P D Robbins, A K House, B J Iacopetta.   

Abstract

The aim of our study was to examine the prognostic significance of p53 protein accumulation and gene mutation in a series of 116 gastric carcinomas from a low incidence population. Formalin-fixed, paraffin-embedded tumour sections were used to investigate p53 protein accumulation by immunostaining with monoclonal antibody (MAb) DO-7 and p53 gene mutation by single-strand conformation polymorphism analysis of exons 5-8. Nuclear p53 accumulation was detected in 23% of tumours and mutation in 28%. Concordance between the 2 alterations was observed in 73% of cases. p53 protein accumulation was more frequent in tumours with lymph node metastasis, while p53 mutations were more frequent in tumours from older patients. The histopathological parameters of depth of invasion, grade and histological type showed no significant associations with either p53 alteration. In univariate analysis, both alterations were associated with significantly shortened patient survival. The 5-year survival rate for patients with a p53 mutation was 9% compared to 42% for those without a mutation. In multivariate analysis adjusted for the other histopathological parameters, p53 gene mutation but not immunohistochemically-detected p53 protein accumulation was an independent prognostic indicator of poor survival in gastric carcinoma.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8682588     DOI: 10.1002/(SICI)1097-0215(19960621)69:3<200::AID-IJC9>3.0.CO;2-3

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  13 in total

1.  The prognostic significance of p53 expression in gastric cancer: a meta-analysis.

Authors:  Kongkong Wei; Lei Jiang; Yaoyao Wei; Yufeng Wang; Xuankun Qian; Qiang Dai; Quanlin Guan
Journal:  J Cancer Res Clin Oncol       Date:  2014-10-15       Impact factor: 4.553

2.  Microsatellite instability and loss of heterozygosity in gastric carcinoma in comparison to family history.

Authors:  G Keller; M Rudelius; H Vogelsang; V Grimm; M G Wilhelm; J Mueller; J R Siewert; H Höfler
Journal:  Am J Pathol       Date:  1998-05       Impact factor: 4.307

3.  Association of p53 genomic instability with the glutathione S-transferase null genotype in gastric cancer in the Portuguese population.

Authors:  A R Conde; G Martins; C Saraiva; J Rueff; C Monteiro
Journal:  Mol Pathol       Date:  1999-06

4.  Expression of p53 and p21 are independent prognostic factors in patients with serosal invasion by gastric carcinoma.

Authors:  M Ikeguchi; H Saito; K Katano; S Tsujitani; M Maeta; N Kaibara
Journal:  Dig Dis Sci       Date:  1998-05       Impact factor: 3.199

5.  p53 mutation pattern and expression of c-erbB2 and c-met in gastric cancer: relation to histological subtypes, Helicobacter pylori infection, and prognosis.

Authors:  Stefan Kubicka; Christiane Claas; Sven Staab; Florian Kühnel; Lars Zender; Christian Trautwein; Siegfried Wagner; Karl Lenhard Rudolph; Michael Manns
Journal:  Dig Dis Sci       Date:  2002-01       Impact factor: 3.199

6.  Alteration of sister chromatid exchange frequencies in gastric cancer and chronic atrophic gastritis patients with and without H. pylori infection.

Authors:  Ali Karaman; Doğan Nasir Binici; Mehmet Eşref Kabalar; Hakan Dursun; Ali Kurt
Journal:  World J Gastroenterol       Date:  2008-04-28       Impact factor: 5.742

7.  Prognostic significance of bcl-2 expression in leiomyosarcoma of the uterus.

Authors:  Y L Zhai; T Nikaido; T Toki; A Shiozawa; A Orii; S Fujii
Journal:  Br J Cancer       Date:  1999-07       Impact factor: 7.640

8.  Prognostic significance of immunohistochemical expression of p53 and retinoblastoma gene protein (pRB) in curatively resected gastric cancer.

Authors:  Hong Suk Song; In Ho Kim; Soo Sang Sohn; Kun Young Kwon; Won Sik Lee
Journal:  Korean J Intern Med       Date:  2005-03       Impact factor: 2.884

9.  Association of TP53 codon 72 polymorphism and the outcome of adjuvant therapy in breast cancer patients.

Authors:  Tatsuya Toyama; Zhenhuan Zhang; Mariko Nishio; Maho Hamaguchi; Naoto Kondo; Hirotaka Iwase; Hiroji Iwata; Satoru Takahashi; Hiroko Yamashita; Yoshitaka Fujii
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466

10.  Exclusive Association of p53 Mutation with Super-High Methylation of Tumor Suppressor Genes in the p53 Pathway in a Unique Gastric Cancer Phenotype.

Authors:  Mina Waraya; Keishi Yamashita; Akira Ema; Natsuya Katada; Shiro Kikuchi; Masahiko Watanabe
Journal:  PLoS One       Date:  2015-10-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.